CLX · NYSE · Household & Personal Products

Clorox (CLX)

Sells branded cleaning, hygiene, household and personal-care products through retail and professional channels.

$85.10
vs last close−2.05 (−2.35%)
Loading prices…

The Clorox CompanyCLX
Consumer Staples

Sells branded cleaning, disinfection, skin-hygiene, bags and wraps, cat litter, grilling, food, water-filtration and personal-care products through retail and professional channels. Health and hygiene now accounts for most sales, while the business remains U.S.-centered and depends heavily on large retailers.

Builds branded consumer and professional categories around Clorox cleaning and disinfecting products, Purell skin hygiene and Clorox Healthcare. Health and Wellness also houses Clorox Professional, while Household spans Glad bags and wraps, Fresh Step and Scoop Away litter, and Kingsford grilling products.

Lifestyle combines Hidden Valley foods, Brita water filtration and Burt’s Bees personal care. International markets laundry, home-care, bags, litter and filtration products outside the United States. Recent portfolio work added GOJO’s Purell business and brought full ownership of Glad in-house.

Competes through product performance, brand investment, innovation, manufacturing and broad retail, distributor and professional-channel reach. Most sales come from U.S. markets, and revenue depends on large retailers, commodity and packaging inputs, product-quality controls and reliable supply chains.

Company facts

CEOLinda J. Rendle
ListedMar 21, 1983
ExchangeNYSE
HeadquartersOakland, CA
CountryUnited States
Employees7,600
CIK0000021076
ISINUS1890541097

Market cap$10.54B
EPS (ttm)$4.81
P/E (ttm)18.12
ROE
P/B117.09
P/S1.57
Dividend yieldDiv yield5.70%
Beta0.29vs XLP 1.26

Price target$98.00+12.4%Average of 29 analysts
ConsensusHold21 of 29 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 4, 2026Deutsche BankTarget
Target: $94
Target: $98
Aug 4, 2026UBSReiterate
Rating: Target: $96
Rating: NeutralTarget: $105
Aug 4, 2026Evercore ISITarget
Target: $98
Target: $99
Aug 4, 2026BarclaysReiterate
Rating: Target: $85
Rating: UnderweightTarget: $84
Jul 28, 2026JefferiesDowngrade
Rating: PositiveTarget: $139
Rating: HoldTarget: $98

Next report
Nov 3, 26
in 41 days
EPS estimate
$1.11
Revenue estimate
$1.88B
Fiscal quarter
Q1 FY27

EPSReportedEstimate

Feb '25May '25Jul '25Nov '25Feb '26Apr '26Aug '26Nov '26
Reported$1.55$1.45$2.87$0.85$1.39$1.64$1.66Pending
Estimate$1.39$1.55$2.20$0.82$1.43$1.55$1.64$1.11
Surprise+11.5%−6.5%+30.5%+3.9%−2.8%+5.8%+1.2%

RevenueReportedEstimate

Feb '25May '25Jul '25Nov '25Feb '26Apr '26Aug '26Nov '26
Reported$1.69B$1.67B$1.99B$1.43B$1.67B$1.67B$1.95BPending
Estimate$1.63B$1.72B$1.93B$1.40B$1.64B$1.67B$1.91B$1.88B
Surprise+3.7%−2.7%+3.1%+2.1%+2.0%0.0%+1.7%
Estimate$1.11
ReportedDue Nov 3, 2026
Estimate$1.88B
ReportedDue Nov 3, 2026
View details

Debt to equity6,133.30%
Current ratio65.80%

ProfitabilityRevenueNet incomeNet margin

Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue$1.76B$1.69B$1.67B$1.99B$1.43B$1.67B$1.67B$1.95B
Net income$99.0M$193.0M$186.0M$332.0M$80.0M$157.0M$187.0M$163.0M
Net margin5.6%11.4%11.2%16.7%5.6%9.4%11.2%8.4%

GrowthOperating income

Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Operating income$288.0M$231.0M$238.0M$420.0M$120.0M$236.0M$284.0M$1.02B
YoY growth+364.5%+56.1%+12.8%+45.8%−58.3%+2.2%+19.3%+143.3%

Balance sheet, Jun 30, 2026Cash & short-term investments $143.0M · Total debt $5.52B · Total assets $7.79B · Shareholders' equity $90.0M

Revenue
$1.95B
Operating income
$1.02B
Net income
$163.0M
View details

Dividend yield
5.70%
Next ex-date
Nov 12, 26
estimated · in 50 days
Annual dividend
$4.97
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Oct '24Jan '25Apr '25Aug '25Oct '25Jan '26Apr '26Aug '26
Dividend$1.22$1.22$1.22$1.24$1.24$1.24$1.24$1.25
Annual yield3.04%3.08%3.51%3.99%4.16%4.54%5.12%4.70%
Ex-dateOct 23Jan 29Apr 23Aug 13Oct 22Jan 28Apr 22Aug 12
Payment dateNov 7Feb 14May 9Aug 29Nov 6Feb 13May 8Aug 28
View details

Institutions87.14%105.38M shares
1,100 holders · as of Jun 30, 2026
Insiders0.55%669.8K shares
14 holders · as of Jul 24, 2026
Other12.31%14.88M shares
remainder

120.92M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
8.31%10.04Mas of Jun 30, 2026
State Street CorpInstitution
6.97%8.43Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
6.53%7.90Mas of Jun 30, 2026
Invesco Ltd.Institution
4.97%6.01Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
4.80%5.80Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
May 5, 2026Pierre R. Breberdirector+5,000$85.82
Nov 21, 2025Pierre R. Breberdirector+4,000$104.13
View details

Compare

CompanyPriceChange
Clorox$85.10−2.35%$10.54B18.114.71.6−2.0%
Procter & Gamble$147.39−0.56%$352.35B22.421.14.0+1.5%
Church & Dwight$95.86−0.28%$22.78B31.024.53.7+1.6%
Reynolds Consumer Products$21.88−1.31%$4.67B13.513.71.2+0.6%
McCormick & Company$48.68−1.50%$13.29B8.215.71.8+16.7%
Ecolab$275.81−0.15%$77.74B37.131.94.6+9.7%
Helen of Troy$29.74+0.84%$686.9M8.10.4+8.2%
Median22.418.42.7+4.9%